Total Payments
$4,055
2024 Payments
$1,052
Companies
35
Transactions
224
Medicare Patients
3,099
Medicare Billing
$232,090
Payment Breakdown by Category
Food & Beverage$4,024 (99.2%)
Education$30.71 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,024 | 221 | 99.2% |
| Education | $30.71 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $448.19 | 32 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $367.74 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $342.54 | 20 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $318.58 | 20 | $0 (2023) |
| Allergan, Inc. | $184.61 | 18 | $0 (2020) |
| Novo Nordisk Inc | $182.76 | 12 | $0 (2024) |
| Lilly USA, LLC | $169.78 | 10 | $0 (2024) |
| Corium, LLC | $155.77 | 12 | $0 (2024) |
| Daiichi Sankyo Inc. | $134.61 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $123.73 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,052 | 56 | AstraZeneca Pharmaceuticals LP ($242.02) |
| 2023 | $485.30 | 31 | Kowa Pharmaceuticals America, Inc. ($207.63) |
| 2022 | $357.22 | 16 | Medtronic, Inc. ($89.85) |
| 2021 | $238.96 | 22 | AbbVie Inc. ($117.56) |
| 2020 | $460.17 | 27 | Allergan, Inc. ($114.38) |
| 2019 | $521.76 | 20 | Janssen Pharmaceuticals, Inc ($151.51) |
| 2018 | $428.91 | 24 | Janssen Pharmaceuticals, Inc ($78.99) |
| 2017 | $510.48 | 28 | Janssen Pharmaceuticals, Inc ($137.24) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Respiratory | ||||||
| 11/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Atland Pharmaceuticals, LLC | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE (Drug), TOLMETIN SODIUM | Food and Beverage | In-kind items and services | $96.25 | General |
| Category: Pain | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 628 | 2,469 | $132,321 | $52,121 |
| 2022 | 17 | 715 | 2,974 | $153,016 | $59,555 |
| 2021 | 16 | 757 | 2,704 | $159,595 | $59,595 |
| 2020 | 22 | 999 | 3,484 | $180,311 | $60,820 |
Total Patients
3,099
Total Services
11,631
Medicare Billing
$232,090
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 423 | $54,990 | $23,576 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 215 | $39,560 | $16,478 | 41.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $6,768 | $4,295 | 63.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 78 | 303 | $12,120 | $2,627 | 21.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $6,118 | $2,283 | 37.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 25 | 26 | $2,028 | $557.06 | 27.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 31 | $1,395 | $502.82 | 36.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 47 | 60 | $1,500 | $487.20 | 32.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $850.00 | $484.50 | 57.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 11 | 11 | $390.00 | $366.69 | 94.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 22 | $550.00 | $209.44 | 38.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 37 | 264 | $1,320 | $89.61 | 6.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 59 | 848 | $3,392 | $67.91 | 2.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 31 | $620.00 | $50.60 | 8.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 28 | 144 | $720.00 | $46.55 | 6.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 451 | $59,454 | $26,028 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 258 | $47,202 | $19,119 | 40.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 84 | 360 | $14,360 | $3,280 | 22.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 21 | 21 | $5,120 | $3,175 | 62.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 48 | 48 | $7,871 | $2,840 | 36.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $3,572 | $2,347 | 65.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 31 | 36 | $2,420 | $732.51 | 30.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 22 | 49 | $1,078 | $714.83 | 66.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $700.00 | $355.68 | 50.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 14 | 14 | $476.00 | $274.17 | 57.6% |
About Dr. Mohammad Aryanpure, MD
Dr. Mohammad Aryanpure, MD is a Family Medicine healthcare provider based in Tuscaloosa, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164439709.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Aryanpure, MD has received a total of $4,055 in payments from pharmaceutical and medical device companies, with $1,052 received in 2024. These payments were reported across 224 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,024).
As a Medicare-enrolled provider, Aryanpure has provided services to 3,099 Medicare beneficiaries, totaling 11,631 services with total Medicare billing of $232,090. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Tuscaloosa, AL
- Active Since 08/02/2006
- Last Updated 02/14/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164439709
Products in Payments
- VRAYLAR (Drug) $325.53
- XARELTO (Drug) $247.34
- UBRELVY (Drug) $225.92
- SEGLENTIS (Drug) $200.84
- Ozempic (Drug) $182.76
- BREZTRI (Drug) $163.70
- Azstarys (Drug) $155.77
- VYVANSE (Drug) $135.62
- Morphabond ER (Drug) $134.61
- INVOKANA (Drug) $120.40
- Vascepa (Drug) $112.14
- Xofluza (Drug) $97.78
- ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE (Drug) $96.25
- ONYX FRONTIER (Device) $89.85
- Evekeo (Drug) $87.50
- Livalo (Drug) $85.91
- REXULTI (Drug) $80.50
- TRELEGY ELLIPTA (Drug) $79.74
- TRULICITY (Drug) $78.27
- GRALISE (Drug) $77.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tuscaloosa
Kelly Hunter, M.d, M.D
Family Medicine — Payments: $54,314
Family Medicine $54,314
Dr. Craig Buettner, Md, MD
Family Medicine — Payments: $20,694
Family Medicine $20,694
Dr. Jeffery Laubenthal, Md, MD
Family Medicine — Payments: $20,425
Family Medicine $20,425
Katherine Grelle, Md, MD
Family Medicine — Payments: $11,665
Family Medicine $11,665
Remona Peterson, Md, MD
Family Medicine — Payments: $8,135
Family Medicine $8,135
William Taunton, M.d, M.D
Family Medicine — Payments: $7,886
Family Medicine $7,886